r

re.Mind Capital

4 employees

re.Mind Capital is a venture capital fund founded by Christian Angermayer, together with partners Jan Hardorp and Max de Vere.

Investor insights

Sectors invested in

Health Care6
Medical5
Biotechnology5
Medical Device4
Software3
Neuroscience3
Wellness2
Artificial Intelligence2
Machine Learning2
neuroscience2
EEG/EMG/EKG1
Life Science1
Virtual Reality1
Gaming1
Personal Health1
stratification1
covid-191
artificial intelligence1
personalized medicine1
photonics1

Funding rounds participated in

$11M sweet spot round size

Most of their 13 investments are in rounds between $4.1M and $40M

Investor type

Venture Capital

Basic info

Industry

venture capital and private equity principals

Sectors

Digital Therapeutics
BCI
Mental Health
Psychedelics
Venture Capital

Date founded

2020

Investments made

P

Precision raised $41M on January 25, 2023

Investors: Forepont Capital Partners, Alumni Ventures Group, Draper Associates, Steadview Capital, B Capital Group and re.Mind Capital

S

Sensorium Therapeutics raised $30M on October 4, 2022

Investors: Ocama Partners, CU Healthcare Innovation Fund, -, Route 66 Ventures, LLC, Palo Santo, Iter Investments and re.Mind Capital

i

iLoF - Intelligent Lab on Fiber raised $4.1M on July 28, 2022

Investors: Alter Venture Partners, FLUXUNIT / ams-OSRAM Ventures, Berggruen Holdings, Quiet Capital, Lunar Ventures, Faber Ventures, M12 - Microsoft's Venture Fund and re.Mind Capital

A

Alena raised $2.7M on March 23, 2022

Investors: Stride.VC and re.Mind Capital

O

OccamzRazor (Razor, inc) raised $6.1M on March 8, 2022

Investors: Lauder Partners, LLC, Valor Equity Partners and re.Mind Capital

C

CereGate raised undisclosed on January 12, 2022

Investors: Heal Capital, High-Tech Gründerfonds, TruVenturo GmbH and re.Mind Capital

O

OpenBCI raised undisclosed on December 15, 2021

Investors: BITKRAFT Ventures, NaHCo3 and re.Mind Capital

U

Undisclosed raised $6.2M on October 31, 2021

Investors: - and re.Mind Capital

N

Neumora raised $400M on October 7, 2021

Investors: Newpath Partners, SoftBank Investment Advisers, Logos Global Management, LP, Surveyor Capital, F-Prime Capital Partners, The Invus Group, Polaris Partners and re.Mind Capital

D

Delix Therapeutics raised $70M on September 27, 2021

Investors: Presight Capital, Palo Santo, PsyMed Ventures, -, OMX Ventures, Saya Bio, RA Capital Management, L.P. and re.Mind Capital

FAQ